Lifan Wang

机构：Central South University, Heilongjiang University of Chinese Medicine, Fudan University, Hefei University, Heilongjiang Academy of Sciences, Zhongshan Hospital, Second Xiangya Hospital of Central South University · ORCID：0000-0002-1806-3152

发表论文 64 篇 · 总被引 604 次 · h-index 12

代表论文

• Regulation of autophagy by the PI3K-AKT pathway in Astragalus membranaceus -Cornus officinalis to ameliorate diabetic nephropathy (2025 · Frontiers in Pharmacology · 被引 10)
• Design, synthesis, in vitro and in vivo biological evaluation of pterostilbene derivatives for anti-inflammation therapy (2024 · Journal of Enzyme Inhibition and Medicinal Chemistry · 被引 10)
• Lipidomics-based natural products for chronic kidney disease treatment (2025 · Heliyon · 被引 9)
• Interoperator reproducibility of quantitative ultrasound analysis of hepatic steatosis in participants with suspected MASLD: A prospective study (2024 · European Journal of Radiology · 被引 7)
• Exploring potential targets for natural product therapy of DN: the role of SUMOylation (2024 · Frontiers in Pharmacology · 被引 6)
• Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease (2024 · Insights into Imaging · 被引 6)